摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-chlorophenyl)-4,6-dimethoxybenzofuran-3(2H)-one | 1403682-27-8

中文名称
——
中文别名
——
英文名称
2-(4-chlorophenyl)-4,6-dimethoxybenzofuran-3(2H)-one
英文别名
2-(4-Chlorophenyl)-4,6-dimethoxy-1-benzofuran-3-one
2-(4-chlorophenyl)-4,6-dimethoxybenzofuran-3(2H)-one化学式
CAS
1403682-27-8
化学式
C16H13ClO4
mdl
——
分子量
304.73
InChiKey
GZZVHADBGVORBJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.67
  • 重原子数:
    21.0
  • 可旋转键数:
    3.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    44.76
  • 氢给体数:
    0.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    2-(4-chlorophenyl)-4,6-dimethoxybenzofuran-3(2H)-one苄基三甲基氢氧化铵 、 zinc(II) iodide 作用下, 以 甲醇乙腈叔丁醇 为溶剂, 反应 3.0h, 生成
    参考文献:
    名称:
    Flavaglines as Potent Anticancer and Cytoprotective Agents
    摘要:
    Flavaglines represent a family of plant natural products that display potent anticancer, Cardioprotective, and neuroprotective activities. Novel flavagline derivatives were synthesized and examined for their cytotoxicity on a panel of human cancer cell lines, their cardioprotection against doxorubicin-induced apoptosis in cardiomyocytes, and their neuroprotection in culture models of Parkinson's disease and cisplatin-induced neurotoxicity. The structural requirements of flavaglines for cardio and neuroprotection were for the first time unraveled and appeared to be slightly different from those for cytotoxicity on cancer cells. We provide also the first evidence that flavaglines may alleviate cisplatin-induced neurotoxicity, suggesting a prophylactic potential of these compounds to prevent this frequently encountered adverse effect of cancer chemotherapies.
    DOI:
    10.1021/jm301201z
  • 作为产物:
    描述:
    2-(4-chlorophenyl)-2-(3,5-dimethoxyphenoxy)acetic acid 在 zinc(II) chloride 、 三氯氧磷 作用下, 以72 %的产率得到2-(4-chlorophenyl)-4,6-dimethoxybenzofuran-3(2H)-one
    参考文献:
    名称:
    WO2023/30685
    摘要:
    公开号:
点击查看最新优质反应信息